No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Texas Health Fort Worth’s Jane and John Justin Tower Set to Open April 2

Editor: What To Know

  • The surgical suites are twice the size of existing operating rooms (ORs) to accommodate modern robotic and imaging technology and are sized to accommodate even larger equipment in the future.
  • “What began as a small community hospital has evolved into a world-class medical center serving the 12th largest city in the U.
  • In addition to the ORs, additional elements of Justin Tower were built with an eye to the future.

Texas Health Fort Worth’s Jane and John Justin Tower opening caps a more than two-year-long, $300 million construction project that adds 400,000 square feet to the hospital.

The nine-story tower, which includes 144 beds, 15 surgery suites, and new pre- and postoperative suites services, is the largest construction project in Texas Health history.

Justin Tower reinforces Texas Health’s long-standing commitment to the Fort Worth community,” said Barclay Berdan, FACHE, CEO of Texas Health Resources and a former president of Texas Health Fort Worth. “What began as a small community hospital has evolved into a world-class medical center serving the 12th largest city in the U.S.”

Justin Tower will increase surgical capacity by almost 30%, with dedicated neurosurgery and orthopedics operating suites. The surgical suites are twice the size of existing operating rooms (ORs) to accommodate modern robotic and imaging technology and are sized to accommodate even larger equipment in the future.

“Our service area includes 1.2 million people in four counties, and that’s expected to grow by another 100,000 over the next five years,” said Joseph DeLeon, president of Texas Health Fort Worth. “The larger, more modern facilities allow us to treat this growing population with specialty services, including trauma, neuroscience, heart and vascular, and many others.”

In addition to the ORs, additional elements of Justin Tower were built with an eye to the future. All patient rooms are private and can be modified to provide varying levels of care, from general medical-surgical to critical care. Additional design elements include the use of natural light, patient-friendly way-finding, and indoor and outdoor spaces for visitors.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy